IVD Raw Materials
Protein purification remains a critical bottleneck in many workflows - impacting timelines, scalability, and overall success.
One of our Quatro ProAb customers, Dr. Justin Byers, founder and CEO at Axio BioPharma, shared their experience about how the automated purification system, Quatro ProAb, accelerates antibody discovery and advances the company’s approach to biomanufacturing.
AmMag™ Quatro ProAb 1300 -
an automated protein and antibody purification instrument
“The impact of Quatro has been remarkable, we’ve reduced hands-on time and labor by 80%, and increased throughput from one run per day to three.”
-- Dr. Justin Byers
By participating in our short survey, you’ll gain exclusive access to the presentation “Accelerating Bioprocess Development with AI + Automation”, delivered by Dr. Justin Byers at the PepTalk protein production conference, where the industry expert discusses:
Help us understand your workflow challenges. Your input will help identify key bottlenecks in protein purification and shape better solutions tailored to your needs.